TIDMRGT 
 
1 February 2011 
 
                             ReGen Therapeutics Plc 
                           ("ReGen" or the "Company") 
 
                              Total Voting Rights 
 
In   accordance   with   the   Financial  Services  Authority's  Disclosure  and 
Transparency Rules, the Company hereby announces that it has 89,446,548 ordinary 
shares  of 0.01p each in issue,  each share carrying the  right to one vote. The 
Company does not hold any ordinary shares in treasury. 
 
The  above figure of  89,446,548 ordinary shares may  be used by shareholders in 
the Company as the denominator for the calculations by which they will determine 
if  they are required to notify their interest in, or a change to their interest 
in,  the share capital  of the Company  under the Financial Services Authority's 
Disclosure and Transparency Rules. 
 
 
Enquiries: 
 
 ReGen Therapeutics Plc               +44 20 7153 4920 
 Percy Lomax 
 
 
 Cairn Financial Advisers LLP         +44 20 7148 7900 
 Nominated Adviser 
 Liam Murray / Avi Robinson 
 
 
 Alexander David Securities Limited   +44 20 7448 9820 
 Broker 
 David Scott / Nick Bealer 
 
 
 
 
 
 
 
 
 
This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
 
Source: ReGen Therapeutics Plc via Thomson Reuters ONE 
 
[HUG#1484275]
Argent Biopharma (LSE:RGT)
Historical Stock Chart
Von Jan 2025 bis Feb 2025 Click Here for more Argent Biopharma Charts.
Argent Biopharma (LSE:RGT)
Historical Stock Chart
Von Feb 2024 bis Feb 2025 Click Here for more Argent Biopharma Charts.